Eagle Pharmaceuticals, Inc. Deferred Revenue
Eagle Pharmaceuticals, Inc. had Deferred Revenue of $0 as of 2016-12-31, per its 10-K filed 2017-03-15.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:DeferredRevenueCurrent · last filed 2017-03-15
- 2016-12-31: Deferred Revenue, Current $0.00.
- 2016-09-30: Deferred Revenue, Current $0.00.
- 2016-06-30: Deferred Revenue, Current $0.00.
- 2016-03-31: Deferred Revenue, Current $0.00.
| Period end | Deferred Revenue, Current | Deferred Revenue, Current as first filed |
|---|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-03-15 | |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $6.00M 10-K · filed 2017-03-15 | |
| 2015-09-30 | $6.00M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $6.26M 10-Q · filed 2015-08-11 | |
| 2015-03-31 | $6.58M 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $6.52M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $6.58M 10-K · filed 2016-02-29 | |
| 2014-06-30 | $6.26M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $9.69M 10-Q · filed 2014-05-15 | |
| 2013-09-30 | $10.02M 10-K · filed 2014-12-22 | $10.02M 10-Q · filed 2014-05-15 |